AU Patent

AU2024216408B2 — Improved bromocriptine formulations

Assigned to Veroscience LLC · Expires 2026-04-30 · 0y expired

What this patent protects

1005469882 The present disclosure describes pharmaceutical formulations of bromocriptine and methods of manufacturing and using such formulations. The formulations are useful for treating physiological disorders including improving glycemic control in the treatment of type 2 diab…

USPTO Abstract

1005469882 The present disclosure describes pharmaceutical formulations of bromocriptine and methods of manufacturing and using such formulations. The formulations are useful for treating physiological disorders including improving glycemic control in the treatment of type 2 diabetes. Also disclosed is synthesis of bromocriptine citrate, and compositions and dosage forms containing bromocriptine citrate.

Drugs covered by this patent

Patent Metadata

Patent number
AU2024216408B2
Jurisdiction
AU
Classification
—
Expires
2026-04-30
Drug substance claim
No
Drug product claim
No
Assignee
Veroscience LLC
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.